Categories

A sample text widget

Etiam pulvinar consectetur dolor sed malesuada. Ut convallis euismod dolor nec pretium. Nunc ut tristique massa.

Nam sodales mi vitae dolor ullamcorper et vulputate enim accumsan. Morbi orci magna, tincidunt vitae molestie nec, molestie at mi. Nulla nulla lorem, suscipit in posuere in, interdum non magna.

Impact of obesity on the liver – Part 2

• Several data have accumulated suggesting that obesity may be associated with liver disease and disease progression.
• Accordingly, the worldwide epidemic of obesity is likely to become a relevant source of morbidity and mortality in the general population.

Liver Disease in Obese Subjects

• A bright liver at ultrasound and increased levels of hepatic enzymes are the hallmarks of the whole spectrum of NAFLD.
• They are common in obesity, and their prevalence increases progressively with increasing BMI.
• At liver biopsy, subjects with moderate or severe fatty change, lipogranulomas, focal necroses, or parenchymal inflammation are significantly more obese than patients without these changes.
• In the general population of the Dionysos study, fatty liver at ultrasonography was documented in 10–15% of normal individuals and in up to 76% of obese subjects not drinking alcohol in toxic amounts.
• Compared with controls, the risk for steatosis was 4.6-fold increased in obese persons and only 5.8-fold higher in persons who were obese and drank heavily.
• Large differences in the prevalence of steatosis exist in the general population.
• In a large, multiethnic, population-based sample where the distribution of hepatic triglyceride content was analyzed.
• It was done by the sensitive proton magnetic resonance spectroscopy.
• Almost one third of the population had hepatic steatosis, and most subjects with hepatic steatosis had normal levels of ALT (79%).

The frequency of hepatic steatosis varied significantly with:
• Ethnicity (45% in Hispanics, 33% in whites, 24% in blacks).
• Sex (42% in white men, 24% in white women).
• The higher prevalence of steatosis in Hispanics was due to the higher prevalence of obesity and insulin resistance.
• Finally, liver fat varies with the degree of obesity.
• In longitudinal studies even small changes in body weight (on average 1.3–2.5 kg) are associated with the ultrasonographic appearance/disappearance of steatosis.
• Compared with ultrasonography, the sensitivity of ALT for the diagnosis of primary NAFLD is much lower.
• Abdominal obesity was one of the most predictive factors of NAFLD.

Pathogenesis of Metabolic Liver Disease

• The role of adipose tissue, namely the central (or upper body) obesity phenotype associated with increased visceral fat, in the pathogenesis of NAFLD is primary.
• Liver fat accumulation is largely dependent on recirculating free fatty acids (FFAs) from the adipose tissue pool.
• The visceral adipose tissue has greater lipolytic potential than the more abundant sc adipose tissue.
• The release of FFA from visceral fat depots directly into the portal circulation is one of the mechanisms of hepatic injury.
• Studies based on proton magnetic resonance spectroscopy have shown that the amount of intrahepatocellular lipids increases by approximately 20% for any 1% increase in total or sc adipose tissue, but doubles for any 1% increase in intraabdominal adipose tissue.
• This explains why even modest changes in visceral fat may cause steatosis.
• Accumulation of triglycerides in the hepatocytes is the result of both increased inflow of FFA and de novo lipogenesis.
• By stable isotope techniques, it has been estimated that in the presence of steatosis 59% of the triglycerides present in the liver arise from re-circulation from adipose tissue, 26% from de novo lipogenesis from dietary carbohydrates—a value much higher than reported in normal subjects—and 15% from dietary lipids.
• In a few cases, steatosis leads to lipotoxicity.

This causes:
– Apoptosis.
– Necrosis.
– Generation of oxidative stress.
– Inflammation.
– The resulting chronic injury activates a fibrogenic response that eventually leads to end-stage liver disease.
– Increased FFA concentrations, in turn, may be responsible for insulin resistance in muscle tissue.
– Whereas in adipose tissue insulin resistance further prevents the insulin-mediated suppression of lipolysis.
– Adipose tissue is an endocrine organ, and over 100 factors secreted by adipose tissue have been identified as potentially responsible for liver lipotoxicity.
– Their secretion is increased with increased visceral fat mass, with the notable exception of adiponectin and chronic inflammation.
– Excess visceral body fat remains a nearly necessary condition.

Nonalcoholic Fatty Liver Disease Fatty Liver You Can Reverse It The Liver Cleansing Diet

Leave a Reply

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>